Covid-19 has hugely affected the modes of interaction between physicians and pharma Sales Force. As of February 2021, most pharma companies in India re-started their F2F visits even though most corporate hospitals have restricted access to salesforce   What is keeping most CEOs awake – How to respond to customer expectations and adjust the content and format accordingly. How to track complexities of implementation of a new model into marketing & sales teams.   Many research reports have indicated that a hybrid (mixed model) that includes face to face and digital interactions are favoured by most respondent Physicians.   The other challenge is the need to change the outdated traditional digital model, which is overused and creates digital noise into an innovative interactive model.  Register Now: https://lnkd.in/gmJK8et

1. Register on: https://lnkd.in/gmJK8et

2. P V Sankar Dass
CEO & Director
Curatio Healthcare (I) Pvt Ltd
Curatio is Dermatology focused company with 200 Cr turnover and
800 people.
Completing the fourth decade in Pharma this year , Sankar started his
career as a MR in Cipla.
Grew to become Vice President-Strategy in Dr.Reddy’s playing
leadership roles in different business verticals of DRL, where he was
recognized for building all the mega brands.
In his tenure of 25 years at DRL he has also worked in different
countries outside India. He is also known for grooming talents in Sales
& Marketing functions.
Register on: https://lnkd.in/gmJK8et

3. Dr. T S PARMAR
MD & CEO, Albert David Ltd.
Over 33 years of experience in the Indian Pharma / Healthcare
Industry with leading MNCs and Indian pharma companies
Wide exposure across the width of functional roles including
Marketing, Sales, Strategy, M&As, General Management etc.
Regular Speaker / Panel Member in leading conferences in India &
Abroad including CPHI, Rotary / Lions, AMA, State CII, Doctor
Associations etc.
Albert David has a turnover of Rs.313 Crores and ranks amongst the
Top 100 pharma companies of India
Register on: https://lnkd.in/gmJK8et

4. Covid-19 has hugely affected the modes of interaction between physicians and pharma Sales Force.
As of February 2021, most pharma companies in India re-started their F2F visits even though most
corporate hospitals have restricted access to sales force
What is keeping most CEOs awake – How to respond to customer expectations and adjust the content and
format accordingly.
How to track complexities of implementation of a new model into marketing & sales teams.
Many research reports have indicated that a hybrid (mixed model) that includes face to face and digital
interactions are favoured by most respondent Physicians.
The other challenge is the need to change the outdated traditional digital model, which is overused and
creates digital noise into an innovative interactive model.
Register on: https://lnkd.in/gmJK8et

5. How have pharma marketing and medical teams
adopted and accepted the new realties?
Key Questions that CEOs will Discuss
Register on: https://lnkd.in/gmJK8et

6. What way are pharma redesigning services
to meet the HCP behavior changes?
Key Questions that CEOs will Discuss
Register on: https://lnkd.in/gmJK8et

7. What are the major challenges in digital adoption?
Overview of the MedicinMan – CredoWeb Survey on Digital Adoption in Indian Pharma
Key Questions that CEOs will Discuss
Register on: https://lnkd.in/gmJK8et

8. 6 Major Challenges in Digital Adoption
1
2
3
4
5
6
Availability of right talent
(internal) (43%)
Sales force resistance
(43%)
Poorly defined benefits
and key outcomes (43%)
Poor communication and
change management process
(46%)
Change in the leadership
priorities (33%)
Availability of right talent
(external) (23%)
MedicinMan Survey

9. What can pharma companies do to
overcome these challenges?
Overview of the MedicinMan – CredoWeb Survey on Digital Adoption in Indian Pharma
Register on: https://lnkd.in/gmJK8et

10. What Pharma can do to build
digitally skilled teams?
Overview of the MedicinMan – CredoWeb Survey on Digital Adoption in Indian Pharma
Key Questions that CEOs will Discuss
Register on: https://lnkd.in/gmJK8et